Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.09 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics Financial Statements 2011-2024 | RVNC

Annual Financial Statements Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

479 M 2.52 B 900 M 1.48 B 970 M 638 M 1.03 B 540 M 505 M 312 M - - -

Shares

84.6 M 72.7 M 67.5 M 58 M 43.5 M 36.2 M 30.1 M 28.1 M 24.3 M 19.4 M - - -

Historical Prices

5.66 34.6 13.3 25.4 22.4 17.3 32.3 20 20.7 16.1 - - -

Net Income

-324 M -356 M -281 M -282 M -159 M -143 M -121 M -89.3 M -73.5 M -62.9 M -52.4 M -58.3 M -44.9 M

Revenue

234 M 133 M 77.8 M 15.3 M 413 K 3.73 M 262 K 300 K 300 K 383 K 617 K 717 K 557 K

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - 617 K 717 K 552 K

Operating Income

-317 M -342 M -275 M -273 M -164 M -143 M -120 M -88.2 M -72.3 M -52 M -38.2 M -43.2 M -

Interest Expense

19.4 M 16.5 M 6.27 M 15.1 M - 44 K 457 K 1.08 M 1.19 M 10.7 M 15.2 M 29 M -

EBITDA

-305 M -308 M -255 M -263 M -162 M -141 M -116 M -77.7 M -70.3 M -50 M -36.3 M -41.4 M -25.8 M

Operating Expenses

- - - - 165 M 146 M 118 M 79.5 M 72.6 M 52.4 M 38.8 M 43.9 M 28.3 M

General and Administrative Expenses

298 M 224 M 199 M 152 M 62 M 53.9 M 37.4 M 29.1 M 25.1 M 19 M - - -

All numbers in USD currency

Quarterly Income Statement Revance Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

104 M 104 M 91.9 M 88 M 86.6 M 83.7 M 81.1 M 82.4 M 72.2 M 70.1 M 68.3 M 71.6 M 67.8 M 67.5 M 66.6 M 69.2 M 60.5 M 54.3 M 53.9 M 52.4 M 43.3 M 43.3 M 41.6 M 37 M 36.3 M 36.1 M 36 M 36.5 M 30.3 M 29.8 M 28.8 M 28.6 M 28.2 M 28.1 M 28 M 28.3 M 23.8 M 23.6 M 23.5 M 23.8 M 23.3 M 19.4 M 11.1 M 261 K 229 K 209 K 204 K - - - - - - - -

Net Income

-38.1 M -37.5 M -53.2 M - -141 M -67.3 M -59.8 M - -84.7 M -61.4 M -64.3 M - -74.4 M -72.2 M -71.6 M - -81.3 M -60.6 M -61.9 M -45.3 M -41.4 M -37.4 M -35.3 M -40.6 M -32.8 M -34.1 M -35 M -40.6 M -30.7 M -26.9 M -27.2 M -26.8 M -18 M -24.6 M -19.9 M -22.1 M -19.2 M -16.8 M -15.4 M -14.2 M -14 M -13.3 M -21.4 M -10.1 M -8.88 M -11.8 M -52.4 M - - - - - - - -

Revenue

59.9 M 65.4 M 51.9 M - 54.1 M 54.4 M 45.8 M - 29 M 28.4 M 25.3 M - 19.7 M 18.8 M 13.3 M - 3.84 M 299 K 58 K 89 K 46 K - 278 K 487 K 2.36 M 686 K 193 K 37 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 75 K 158 K 309 K 158 K 75 K 75 K - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - 21 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 158 K - - - 75 K - - - - - - - -

Operating Income

-32.3 M -34.5 M -46.8 M - -37.6 M -56.3 M -46.7 M - -77.5 M -57.8 M -62.2 M - -72.7 M -70.3 M -70 M - -77.1 M -57.1 M -61 M -46.2 M -42.5 M -39.1 M -36.6 M -38.4 M -33.6 M -34.9 M -35.7 M - -30.7 M -26.8 M -27.1 M - -17.7 M -24.1 M -19.7 M - -18.8 M -16.6 M -15.2 M - -13.8 M -12.9 M -11.5 M - -8.27 M -11.3 M -9.68 M - - - - - - - -

Interest Expense

-258 K -453 K 5.26 M - -223 K -599 K 4.5 M - 6.92 M 3.87 M 1.93 M - 1.57 M 1.57 M 1.56 M - 4.33 M 4.26 M 2.15 M - - - - - - - 44 K - 104 K 141 K 193 K - 256 K 286 K 315 K - 390 K 279 K 165 K - 228 K 267 K 9.84 M - 351 K 490 K 12.6 M - - - - - - - -

EBITDA

-31.7 M -34 M -44.8 M - -37.2 M -55.6 M -42.4 M - -73.6 M -53.9 M -56.8 M - -58.3 M -61.1 M -65.8 M - -71.2 M -55 M -60.2 M -46.2 M -40.4 M -37.7 M -36 M -38.4 M -32.4 M -34.1 M -35.3 M - -29.6 M -26.1 M -26.7 M - -16.7 M -23.4 M -19.4 M - -17.2 M -15.5 M -14.6 M - -13.2 M -12.4 M -11 M - -7.87 M -10.9 M -9.22 M - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - 61 M - 42.6 M 39.1 M 36.9 M - 36 M 35.6 M 35.9 M - 30.8 M 26.9 M 27.2 M - 17.8 M 24.2 M 19.8 M - 18.8 M 16.7 M 15.2 M - 13.9 M 13 M 11.6 M - 8.43 M 11.4 M 9.75 M - - - - - - - -

General and Administrative Expenses

62.6 M 65.8 M 68.9 M - 65.8 M 74.8 M 61.9 M - 65.8 M 47.8 M 45.1 M - 52.8 M 50.6 M 49 M - 48.2 M 29.6 M 21.2 M - 16.7 M 13.6 M 12.9 M - 14.2 M 12.7 M 13.6 M - 9.15 M 8.61 M 7.75 M - 7.5 M 7.02 M 7.46 M - 5.83 M 6.36 M 6 M - 5.3 M 4.86 M 4.09 M - 2.14 M 3.64 M 2.22 M - - - - - - - -

All numbers in USD currency